X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19914) 19914
Book Review (2884) 2884
Publication (1499) 1499
Newsletter (534) 534
Book Chapter (87) 87
Conference Proceeding (35) 35
Magazine Article (32) 32
Newspaper Article (18) 18
Book / eBook (14) 14
Dissertation (14) 14
Reference (10) 10
Trade Publication Article (7) 7
Paper (2) 2
Web Resource (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (16398) 16398
humans (8700) 8700
animals (7996) 7996
escherichia-coli (7356) 7356
escherichia coli (6911) 6911
microbiology (5578) 5578
female (4516) 4516
bacteria (4256) 4256
male (4060) 4060
infectious diseases (3621) 3621
infections (2853) 2853
immunology (2700) 2700
mice (2695) 2695
health aspects (2689) 2689
analysis (2570) 2570
e coli (2365) 2365
antibiotics (2324) 2324
research (2281) 2281
mortality (2177) 2177
infection (2112) 2112
virulence (1980) 1980
anti-bacterial agents - pharmacology (1930) 1930
middle aged (1801) 1801
adult (1750) 1750
pathogens (1741) 1741
escherichia coli infections - microbiology (1692) 1692
research article (1684) 1684
proteins (1657) 1657
escherichia coli - isolation & purification (1637) 1637
microbial sensitivity tests (1598) 1598
aged (1595) 1595
epidemiology (1583) 1583
drug resistance (1533) 1533
risk factors (1495) 1495
escherichia coli - genetics (1471) 1471
escherichia coli - drug effects (1441) 1441
veterinary sciences (1430) 1430
medicine (1405) 1405
genes (1389) 1389
anti-bacterial agents - therapeutic use (1356) 1356
drug resistance in microorganisms (1325) 1325
biotechnology & applied microbiology (1315) 1315
pharmacology & pharmacy (1309) 1309
biochemistry & molecular biology (1241) 1241
diarrhea (1239) 1239
multidisciplinary sciences (1226) 1226
resistance (1214) 1214
salmonella (1210) 1210
abridged index medicus (1196) 1196
sepsis (1180) 1180
bacterial infections (1175) 1175
prevalence (1173) 1173
antimicrobial resistance (1139) 1139
antimicrobial agents (1093) 1093
gene expression (1050) 1050
infant (998) 998
physiological aspects (981) 981
disease models, animal (971) 971
strains (966) 966
escherichia coli infections - epidemiology (960) 960
identification (958) 958
science (957) 957
expression (938) 938
adolescent (936) 936
bacteremia (933) 933
genetic aspects (922) 922
child (918) 918
risk-factors (914) 914
medical research (908) 908
studies (904) 904
enterobacteriaceae (895) 895
child, preschool (885) 885
gram-negative bacteria (885) 885
public health (879) 879
escherichia coli infections - veterinary (857) 857
escherichia coli infections - drug therapy (851) 851
swine (849) 849
drug resistance, bacterial (844) 844
molecular sequence data (844) 844
article (843) 843
vaccines (841) 841
bacterial proteins - genetics (840) 840
escherichia coli - pathogenicity (839) 839
staphylococcus-aureus (822) 822
biology (812) 812
infant, newborn (809) 809
pseudomonas-aeruginosa (809) 809
antibiotic resistance (799) 799
food science & technology (784) 784
rats (779) 779
retrospective studies (773) 773
children (766) 766
klebsiella-pneumoniae (766) 766
life sciences (759) 759
aged, 80 and over (754) 754
inflammation (744) 744
antibacterial agents (735) 735
cattle (735) 735
medicine, research & experimental (724) 724
hospitals (717) 717
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20232) 20232
German (77) 77
Spanish (67) 67
French (60) 60
Russian (26) 26
Chinese (20) 20
Polish (15) 15
Turkish (13) 13
Korean (9) 9
Portuguese (9) 9
Dutch (8) 8
Japanese (8) 8
Italian (7) 7
Bulgarian (6) 6
Czech (6) 6
Danish (6) 6
Romanian (5) 5
Croatian (2) 2
Hungarian (2) 2
Norwegian (2) 2
Lithuanian (1) 1
Serbian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, ISSN 0098-7484, 09/2018, Volume 320, Issue 10, pp. 984 - 994
IMPORTANCE Extended-spectrum beta-lactamases mediate resistance to third-generation cephalosporins (eg, ceftriaxone) in Escherichia coli and Klebsiella... 
UNITED-STATES | MEDICINE, GENERAL & INTERNAL | EXTENDED-SPECTRUM | CEFEPIME | THERAPY | BACTEREMIA | LACTAMASE-PRODUCING ENTEROBACTERIACEAE | SPECTRUM BETA-LACTAMASES | EXTENSION | Escherichia coli Infections - mortality | Klebsiella pneumoniae - drug effects | Escherichia coli - drug effects | Humans | Middle Aged | Drug Resistance, Bacterial | Bacteremia - mortality | Ceftriaxone - pharmacology | Male | Cause of Death | Anti-Bacterial Agents - therapeutic use | Penicillanic Acid - therapeutic use | Adult | Female | Anti-Bacterial Agents - adverse effects | Meropenem | Penicillanic Acid - adverse effects | Thienamycins - adverse effects | Penicillanic Acid - analogs & derivatives | Thienamycins - therapeutic use | Escherichia coli Infections - drug therapy | Klebsiella Infections - drug therapy | Piperacillin, Tazobactam Drug Combination | Bacteremia - drug therapy | Piperacillin - adverse effects | Klebsiella Infections - mortality | Aged | Anti-Bacterial Agents - pharmacology | Piperacillin - therapeutic use | Klebsiella | Treatment outcome | Safety and security measures | Tazobactam | Escherichia coli | Patient outcomes | Analysis | Comparative analysis | Risk factors | Bacterial infections | Intravenous administration | Mortality | Clinical trials | Piperacillin-tazobactam | Infections | Ceftriaxone | Drug resistance | Patients | Side effects | Randomization | Cephalosporins | Piperacillin | Drug therapy | Blood diseases | Blood culture | Carbapenems | Index Medicus | Abridged Index Medicus | Original Investigation | Research
Journal Article
Journal of Infection, ISSN 0163-4453, 2014, Volume 69, Issue 3, pp. 216 - 225
Summary Background An intervention for Gram-negative bloodstream infections that integrated mass spectrometry technology for rapid diagnosis with antimicrobial... 
Infectious Disease | Bloodstream infections | Multidrug resistant | Antimicrobial stewardship | MALDI-TOF | Rapid diagnostics | MORTALITY | ACQUIRED INFECTIONS | INFECTIOUS DISEASES | METAANALYSIS | IDENTIFICATION | DISEASES SOCIETY | IMPACT | THERAPY | HEALTH-CARE | BLOOD-STREAM INFECTIONS | ENTEROBACTERIACEAE | Humans | Middle Aged | Bacteremia - mortality | Male | Pseudomonas Infections - mortality | Gram-Negative Bacterial Infections - microbiology | Time Factors | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Escherichia coli Infections - drug therapy | Escherichia coli - enzymology | Time-to-Treatment | Bacteremia - drug therapy | Klebsiella - enzymology | Gram-Negative Bacterial Infections - drug therapy | Pseudomonas Infections - diagnosis | Survival Rate | Pseudomonas Infections - microbiology | Klebsiella Infections - diagnosis | Gram-Negative Bacterial Infections - diagnosis | Hospital Costs | Escherichia coli Infections - mortality | Pseudomonas aeruginosa - isolation & purification | beta-Lactam Resistance | Acinetobacter Infections - mortality | Klebsiella - isolation & purification | Bacteremia - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Drug Resistance, Multiple, Bacterial | Acinetobacter baumannii - isolation & purification | Adult | Female | beta-Lactamases - metabolism | Acinetobacter Infections - microbiology | Length of Stay | Escherichia coli Infections - diagnosis | Intensive Care Units | Klebsiella Infections - drug therapy | Acinetobacter Infections - diagnosis | Hospital Mortality | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Treatment Outcome | Bacteremia - diagnosis | Klebsiella Infections - microbiology | Escherichia coli - isolation & purification | Klebsiella Infections - mortality | Aged | Gram-Negative Bacterial Infections - mortality | Drug resistance in microorganisms | Care and treatment | Mass spectrometry | Patient outcomes | Index Medicus
Journal Article
Journal Article
Journal of Infection, ISSN 0163-4453, 2007, Volume 55, Issue 3, pp. 254 - 259
Summary Objectives To determine the differences in mortality and length of hospital stay in patients with bacteraemic infection caused by ESBL and non-ESBL... 
Infectious Disease | Bacteraemia | Death | ESBL producing E. coli | Mortality | INFECTIOUS DISEASES | URINARY-TRACT-INFECTIONS | RISK-FACTORS | death | ANTIMICROBIAL THERAPY | bacteraemia | VIRULENCE FACTORS | COMMUNITY | PIPERACILLIN/TAZOBACTAM | mortality | OUTCOMES | BLOOD-STREAM INFECTIONS | KLEBSIELLA-PNEUMONIAE | ENTEROBACTERIACEAE | Escherichia coli Infections - mortality | Prospective Studies | Community-Acquired Infections - epidemiology | Escherichia coli - drug effects | Humans | Middle Aged | Male | beta-Lactamases - biosynthesis | Bile Duct Diseases - epidemiology | Anti-Bacterial Agents - therapeutic use | Cross Infection - pathology | England - epidemiology | Escherichia coli - metabolism | Adult | Female | Urinary Tract Infections - pathology | Odds Ratio | Drug Resistance | Length of Stay - statistics & numerical data | Cross Infection - epidemiology | Escherichia coli Infections - drug therapy | Imipenem - pharmacology | Escherichia coli Infections - epidemiology | Urinary Tract Infections - epidemiology | Escherichia coli Infections - pathology | Community-Acquired Infections - pathology | Escherichia coli - isolation & purification | Adolescent | Aged | Anti-Bacterial Agents - pharmacology | Bacteremia - pathology | Bile Duct Diseases - pathology | Beta lactamases | Comparative analysis | Health aspects | Escherichia coli | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2015, Volume 10, Issue 12, pp. e0142927 - e0142927
Journal Article
Journal Article
Infection Control and Hospital Epidemiology, ISSN 0899-823X, 06/2018, Volume 39, Issue 6, pp. 660 - 667
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2012, Volume 56, Issue 2, pp. 618 - 622
Journal Article
Journal of Vascular Surgery, ISSN 0741-5214, 2013, Volume 58, Issue 5, pp. 1179 - 1185
Objective The management of infected aortic endografts is a challenging endeavor. Treatment of this problem has not been well defined as it is fairly uncommon.... 
Surgery | SURGERY | STENT GRAFT INFECTION | PERIPHERAL VASCULAR DISEASE | Device Removal | Escherichia coli Infections - mortality | Aortic Aneurysm, Abdominal - mortality | Aortic Aneurysm, Abdominal - surgery | Blood Vessel Prosthesis - adverse effects | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Prosthesis Design | Anti-Bacterial Agents - therapeutic use | Aortography - methods | Endovascular Procedures - instrumentation | Escherichia coli Infections - therapy | Blood Vessel Prosthesis Implantation - adverse effects | Prosthesis-Related Infections - microbiology | Aged, 80 and over | Aortic Aneurysm, Thoracic - mortality | Female | Prosthesis-Related Infections - diagnosis | Retrospective Studies | Staphylococcal Infections - microbiology | Prosthesis-Related Infections - mortality | Reoperation | Escherichia coli Infections - diagnosis | Blood Vessel Prosthesis Implantation - instrumentation | Endovascular Procedures - adverse effects | Escherichia coli Infections - microbiology | Treatment Outcome | Endovascular Procedures - mortality | Blood Vessel Prosthesis Implantation - mortality | Prosthesis-Related Infections - therapy | Staphylococcal Infections - therapy | Staphylococcal Infections - mortality | Staphylococcal Infections - diagnosis | Aortic Aneurysm, Thoracic - surgery | Aged | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Aneurysms | Health aspects | Index Medicus
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, pp. e54714 - e54714
Background: National statistics in developing countries are likely to underestimate deaths due to bacterial infections. Here, we calculated mortality... 
IMPACT | ESCHERICHIA-COLI BACTEREMIA | TYPHOID-FEVER | MULTIDISCIPLINARY SCIENCES | POPULATION-BASED COHORT | ANTIBIOTIC-RESISTANCE | BLOOD-STREAM INFECTIONS | MELIOIDOSIS | Escherichia coli Infections - mortality | Humans | Middle Aged | Thailand - epidemiology | Child, Preschool | Infant | Male | Burkholderia pseudomallei - isolation & purification | Young Adult | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Burkholderia pseudomallei - pathogenicity | Escherichia coli - pathogenicity | Aged, 80 and over | Adult | Female | beta-Lactamases - metabolism | Child | Infant, Newborn | Community-Acquired Infections - mortality | Staphylococcus aureus - isolation & purification | Staphylococcus aureus - pathogenicity | Escherichia coli Infections - epidemiology | Staphylococcal Infections - mortality | Staphylococcal Infections - epidemiology | Escherichia coli - isolation & purification | Adolescent | Klebsiella Infections - mortality | Aged | Community-Acquired Infections - microbiology | Klebsiella pneumoniae | Microbiology | Beta lactamases | Bacteremia | Klebsiella | Pediatrics | Laboratories | Communities | Escherichia coli | Developing countries | Infections | Drug resistance | Developing nations | Epidemiology | Data bases | Developing countries--LDCs | Incidence | Respiratory tract | Ethics | Databases | E coli | Bacteria | Population | Respiratory tract diseases | Burkholderia | Trends | Public health | Bacterial infections | Mortality | Typhoid | Patients | Statistics | Medicine | Hospitals | Tuberculosis | Infectious diseases | Antibiotics | Surveillance | Death | Index Medicus | LDCs
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 07/2013, Volume 57, Issue 7, pp. 3092 - 3099
Journal Article